The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback